Skip to main content
Erschienen in: Journal of Cancer Education 4/2020

19.03.2020

Diagnosis of Cutaneous Melanoma: the Gap Between the Knowledge of General Practitioners and Dermatologists in a Brazilian Population

verfasst von: Andrea Quadros Garrido, Alberto Julius Alves Wainstein, Marina Patrus Ananias Brandão, Fernando Augusto de Vasconcellos Santos, Flavia Vasques Bittencourt, Carolina Ledsham, Ana Paula Drummond-Lage

Erschienen in: Journal of Cancer Education | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

The early diagnosis of cutaneous melanoma provides less aggressive treatment reducing mortality. General practitioners are responsible for cancer diagnoses in the Brazilian Public Health System and therefore play a crucial role in the prevention and early detection of melanoma. To assess the melanoma knowledge of a primary healthcare physician, the general practitioner, compared to a dermatologist. General practitioners and dermatologists answered a questionnaire about melanoma and the management of suspected cases. The results of both groups were compared. The sample consisted of 80 specialists and 160 general practitioners. When asked about the “ABCDE” rule, 96.2% of the dermatologists knew about it, compared to 34.4% of the general practitioners. The percentage of dermatologists who examined the whole skin of the patient at high risk for melanoma was 90% vs. 24.5% amongst general practitioners. The most cited reasons for the absence of the examination of patients at risk for melanoma were lack of time at the consultations (17.6% specialists, 66.1% generalists) and an excessive number of patients (17.6% specialists, 61.5% generalists). General practitioner has less knowledge about melanoma compared to the dermatologists and presents deficient behaviors about patients at risk or who have suspicious lesions, indicating the need for training and continuing education.
Literatur
2.
Zurück zum Zitat Shandendorf D, Akkooi ACJ, Berking C, Grienwank KG, Gutzmer R, Hauschild A et al (2018) Melanoma. Lancet. 392:971–984CrossRef Shandendorf D, Akkooi ACJ, Berking C, Grienwank KG, Gutzmer R, Hauschild A et al (2018) Melanoma. Lancet. 392:971–984CrossRef
3.
Zurück zum Zitat Wainstein AJA, Belford FA (2014) Melanoma: prevenção, diagnóstico, tratamento e acompanhamento. 2° edição. Atheneu, São Paulo Wainstein AJA, Belford FA (2014) Melanoma: prevenção, diagnóstico, tratamento e acompanhamento. 2° edição. Atheneu, São Paulo
4.
Zurück zum Zitat Watts CG, Dieng M, Morten ML, Mann CJ, Menzes SJ, Cust AE (2015) Melanoma clinical practice guidelines: a systematic review. Br J Dermatol 172:33–47CrossRef Watts CG, Dieng M, Morten ML, Mann CJ, Menzes SJ, Cust AE (2015) Melanoma clinical practice guidelines: a systematic review. Br J Dermatol 172:33–47CrossRef
5.
Zurück zum Zitat Souza SRP, Fischer FM, Souza JMP (2004) Bronzeamento e risco de melanoma cutâneo: revisão da literatura. Rev SaúdePública 38(4):588–598 Souza SRP, Fischer FM, Souza JMP (2004) Bronzeamento e risco de melanoma cutâneo: revisão da literatura. Rev SaúdePública 38(4):588–598
6.
Zurück zum Zitat Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A et al (2016) NCCN: clinical practice guidelines in oncology for melanoma. J Natl Compr Cancer Netw 14(4):450–473CrossRef Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A et al (2016) NCCN: clinical practice guidelines in oncology for melanoma. J Natl Compr Cancer Netw 14(4):450–473CrossRef
7.
Zurück zum Zitat Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI et al (2017) Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67(6):472–492CrossRef Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI et al (2017) Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67(6):472–492CrossRef
8.
Zurück zum Zitat Xavier MHSB, Drummond-Lage AP, Baeta C, Rocha L, Almeida MA, Wainstein AJA (2016) Delay in cutaneous melanoma diagnosis. Medicine. 95(31):1–5CrossRef Xavier MHSB, Drummond-Lage AP, Baeta C, Rocha L, Almeida MA, Wainstein AJA (2016) Delay in cutaneous melanoma diagnosis. Medicine. 95(31):1–5CrossRef
9.
Zurück zum Zitat Richard MA, Grob JJ, Avril MF, Delaunay M, Gouvernet J, Wolkemstein P, Souteyrand P et al (2000) Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer (Pred Oncol) 89:280–285CrossRef Richard MA, Grob JJ, Avril MF, Delaunay M, Gouvernet J, Wolkemstein P, Souteyrand P et al (2000) Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer (Pred Oncol) 89:280–285CrossRef
10.
Zurück zum Zitat Richard MA, Grob JJ, Avril MF, Delaunay M, Gouvernet J, Wolkemstein P et al (2000) Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer (Pred Oncol) 89:171–179 Richard MA, Grob JJ, Avril MF, Delaunay M, Gouvernet J, Wolkemstein P et al (2000) Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer (Pred Oncol) 89:171–179
11.
Zurück zum Zitat Salvio AG, Assumpção Júnior A, Segalla JGM, Panfilo BL, Nicolini HR (2011) DidoneR.Experiência de um ano de modelo de programa de prevenção contínua do melanoma na cidade de Jaú-SP, Brasil. An Bras Dermatol. 86(4):669–674CrossRef Salvio AG, Assumpção Júnior A, Segalla JGM, Panfilo BL, Nicolini HR (2011) DidoneR.Experiência de um ano de modelo de programa de prevenção contínua do melanoma na cidade de Jaú-SP, Brasil. An Bras Dermatol. 86(4):669–674CrossRef
12.
Zurück zum Zitat Ministério da saúde. PNAB: Política Nacional de Atenção Básica; Brasília- DF. 2012 Ministério da saúde. PNAB: Política Nacional de Atenção Básica; Brasília- DF. 2012
13.
Zurück zum Zitat McIlfatrick S, Keeney S, McKenna H, McCarley N (2013) Investigating the role of the general practitioner in cancer prevention: a mixed methods study. BMC Fam Pract:14–58 McIlfatrick S, Keeney S, McKenna H, McCarley N (2013) Investigating the role of the general practitioner in cancer prevention: a mixed methods study. BMC Fam Pract:14–58
14.
Zurück zum Zitat Maia M, Basso M (2006) Quem descobre o melanoma cutâneo. An Bras Dermatol 81(3):244–248CrossRef Maia M, Basso M (2006) Quem descobre o melanoma cutâneo. An Bras Dermatol 81(3):244–248CrossRef
15.
Zurück zum Zitat Silva LMC, Fonseca AJ, Ferreira LP, Dalla-Benetta AC, Navarro C (2011) Atitude e Conhecimento de Médicos da Estratégia Saúde da Família sobre Prevenção e Rastreamento do Câncer. Rev Bras Cancerol 57(4):525–534 Silva LMC, Fonseca AJ, Ferreira LP, Dalla-Benetta AC, Navarro C (2011) Atitude e Conhecimento de Médicos da Estratégia Saúde da Família sobre Prevenção e Rastreamento do Câncer. Rev Bras Cancerol 57(4):525–534
16.
Zurück zum Zitat Tucunduva LTCM, Sá VHLC, Koshimura ET, Prudente FVB, Santos AF, Samano ES et al (2004) Estudo da atitude e do conhecimento dos médicos não oncologistas em relação às medidas de prevenção e rastreamento do câncer. Rev Assoc Med Bras 50(3):257–262CrossRef Tucunduva LTCM, Sá VHLC, Koshimura ET, Prudente FVB, Santos AF, Samano ES et al (2004) Estudo da atitude e do conhecimento dos médicos não oncologistas em relação às medidas de prevenção e rastreamento do câncer. Rev Assoc Med Bras 50(3):257–262CrossRef
17.
Zurück zum Zitat Geller AC, Venna S, Prout M, Miller DR, Demierre MF, Koh HK, Gilchrest BA (2002) Should the skin cancer examination be taught in medical school. Arch Dermatol 138:1201–1203CrossRef Geller AC, Venna S, Prout M, Miller DR, Demierre MF, Koh HK, Gilchrest BA (2002) Should the skin cancer examination be taught in medical school. Arch Dermatol 138:1201–1203CrossRef
18.
Zurück zum Zitat Garg A, Wang J, Reddy SB, Powers J, Jacob R, Powers M, Biello K, Cayce R, Savory S, Belazarian L, Domingues E, Korzenko A, Wilson L, Grant-Kels JM, George P, Robinson-Bostom L, Trotter SC, Geller AC, Integrated Skin Exam Consortium (2014) Curricular factors associated with medical students practice of the skin cancer examination. An educational enhancement initiative by the integrated skin exam consortium. JAMA Dermatol 150(8):850–855CrossRef Garg A, Wang J, Reddy SB, Powers J, Jacob R, Powers M, Biello K, Cayce R, Savory S, Belazarian L, Domingues E, Korzenko A, Wilson L, Grant-Kels JM, George P, Robinson-Bostom L, Trotter SC, Geller AC, Integrated Skin Exam Consortium (2014) Curricular factors associated with medical students practice of the skin cancer examination. An educational enhancement initiative by the integrated skin exam consortium. JAMA Dermatol 150(8):850–855CrossRef
19.
Zurück zum Zitat Moore MM, Geller AC, Zhang Z, Hayes BB, Bergstrom K, Graves JE, Kim A, Martinez JC, Shahabi L, Miller DR, Gilchrest BA (2006) Skin cancer examination teaching in US medical education. Arch Dermatol 142:439–444CrossRef Moore MM, Geller AC, Zhang Z, Hayes BB, Bergstrom K, Graves JE, Kim A, Martinez JC, Shahabi L, Miller DR, Gilchrest BA (2006) Skin cancer examination teaching in US medical education. Arch Dermatol 142:439–444CrossRef
20.
Zurück zum Zitat Goulart JM, Quegley EA, Dusza S, Jewell ST, Alexander G, Asgari MM, Eide MJ et al (2011) Skin cancer education for primary care physicians: a systematic review of published evaluated interventions. J Gen Intern Med 26(9):1027–1035CrossRef Goulart JM, Quegley EA, Dusza S, Jewell ST, Alexander G, Asgari MM, Eide MJ et al (2011) Skin cancer education for primary care physicians: a systematic review of published evaluated interventions. J Gen Intern Med 26(9):1027–1035CrossRef
22.
Zurück zum Zitat Melo AC, Wainstein AJA, Buzaid AC, Thuler LCS. Melanoma signature in Brazil: epidemiology, incidence, mortality, and trend lessons from a continental mixed population country in the past 15 years. Melanoma Res 2018; 00:000–0 Melo AC, Wainstein AJA, Buzaid AC, Thuler LCS. Melanoma signature in Brazil: epidemiology, incidence, mortality, and trend lessons from a continental mixed population country in the past 15 years. Melanoma Res 2018; 00:000–0
24.
Zurück zum Zitat Lutz K, Hayward V, Joseph M, Wong E, Temple-Oberle C (2014) Current biopsy practices for suspected melanoma: a survey of family physicians in Southwestern Ontario. Plast Surg Canada 22(3):175–178CrossRef Lutz K, Hayward V, Joseph M, Wong E, Temple-Oberle C (2014) Current biopsy practices for suspected melanoma: a survey of family physicians in Southwestern Ontario. Plast Surg Canada 22(3):175–178CrossRef
25.
Zurück zum Zitat Herath HMMTB, Keragala BSDP, Udeshika WAE, Samarawickrama SSM, Pahalagamage SP, Kulatunga A et al (2018) Knowledge, attitudes and skills in melanoma diagnosis among doctors: a cross-sectional study from Sri Lanka. BMC Res Notes 11(1):389–394CrossRef Herath HMMTB, Keragala BSDP, Udeshika WAE, Samarawickrama SSM, Pahalagamage SP, Kulatunga A et al (2018) Knowledge, attitudes and skills in melanoma diagnosis among doctors: a cross-sectional study from Sri Lanka. BMC Res Notes 11(1):389–394CrossRef
26.
Zurück zum Zitat Esposito C, Pezzulo L, Napolitano F, Di Giuseppe G (2016) Melanoma prevention in children: knowledge, attitudes, and behaviors of pediatricians in Italy. Ann Ist Super Sanita 52(4):570–575PubMed Esposito C, Pezzulo L, Napolitano F, Di Giuseppe G (2016) Melanoma prevention in children: knowledge, attitudes, and behaviors of pediatricians in Italy. Ann Ist Super Sanita 52(4):570–575PubMed
27.
Zurück zum Zitat Zimmerlé V, Laurent E, Tauveron V, Maruani A, Le Bidre E, Samimi M et al (2018) Reconnaissance et pise em charge initialedu melanoma par de médecinsgeneralistes: enquete dansundépartament rural à três faibledensitémédicale. Presse Med 47(4):35–42CrossRef Zimmerlé V, Laurent E, Tauveron V, Maruani A, Le Bidre E, Samimi M et al (2018) Reconnaissance et pise em charge initialedu melanoma par de médecinsgeneralistes: enquete dansundépartament rural à três faibledensitémédicale. Presse Med 47(4):35–42CrossRef
28.
Zurück zum Zitat Badertscher N, Senn O, Rossi PO, Wensing M, Rosemann T (2003) Tandjung, Ryan. Hautkrebs in der Hausarztpraxis: Häufigkeit, Fortbildungsbedarf und subjektiveDiagnosesicherheit. Eine UmfrageunterZürcherHausärzten. Praxis. 102(22):1353–1359CrossRef Badertscher N, Senn O, Rossi PO, Wensing M, Rosemann T (2003) Tandjung, Ryan. Hautkrebs in der Hausarztpraxis: Häufigkeit, Fortbildungsbedarf und subjektiveDiagnosesicherheit. Eine UmfrageunterZürcherHausärzten. Praxis. 102(22):1353–1359CrossRef
29.
Zurück zum Zitat Janda M, Elwood M, Ring IT, Friman DW, Lowe JB, Youl PH et al (2004) Prevalence of skin screening by general practitioners in regional Queensland. MJA. 180:10–15PubMed Janda M, Elwood M, Ring IT, Friman DW, Lowe JB, Youl PH et al (2004) Prevalence of skin screening by general practitioners in regional Queensland. MJA. 180:10–15PubMed
30.
Zurück zum Zitat Abbasi RN, Shaw HM, Riegel DS, Friedman RJ, McCarthy WH, Osman I et al (2004) Early diagnosis of cutaneous melanoma revisiting the ABCD criteria. JAMA. 292(22):2771–2776CrossRef Abbasi RN, Shaw HM, Riegel DS, Friedman RJ, McCarthy WH, Osman I et al (2004) Early diagnosis of cutaneous melanoma revisiting the ABCD criteria. JAMA. 292(22):2771–2776CrossRef
31.
Zurück zum Zitat Gerbert B, Maurer T, Berger T, Pantilat S, McPhee SJ, Wolff M, Bronstone A, Caspers N (1996) Primary care physicians as gatekeepers in managed care. Primary care physicians’ and dermatologists’ skills at secondary prevention of skin cancer. Arch Dermatol 132(9):1030–1038CrossRef Gerbert B, Maurer T, Berger T, Pantilat S, McPhee SJ, Wolff M, Bronstone A, Caspers N (1996) Primary care physicians as gatekeepers in managed care. Primary care physicians’ and dermatologists’ skills at secondary prevention of skin cancer. Arch Dermatol 132(9):1030–1038CrossRef
32.
Zurück zum Zitat Krige JE, Isaacs S, Hudson DA, King HS, Strover RM, Johnson CA (1991) Delay in the diagnosis of cutaneous malignant melanoma. A prospective study in 250 patients. Cancer. 68(9):2061–2068CrossRef Krige JE, Isaacs S, Hudson DA, King HS, Strover RM, Johnson CA (1991) Delay in the diagnosis of cutaneous malignant melanoma. A prospective study in 250 patients. Cancer. 68(9):2061–2068CrossRef
33.
Zurück zum Zitat Robinson JK, Turrisi R (2006) Skills training to learn discrimination of ABCDE criteria by those at risk of developing melanoma. Arch Dermatol 142:447–452PubMed Robinson JK, Turrisi R (2006) Skills training to learn discrimination of ABCDE criteria by those at risk of developing melanoma. Arch Dermatol 142:447–452PubMed
34.
Zurück zum Zitat Jackson AM, Morgan DR, Ellison R (2000) Diagnosis of malignant melanoma by general practitioners and hospital specialists. Postgrad Med J 76:295–298CrossRef Jackson AM, Morgan DR, Ellison R (2000) Diagnosis of malignant melanoma by general practitioners and hospital specialists. Postgrad Med J 76:295–298CrossRef
Metadaten
Titel
Diagnosis of Cutaneous Melanoma: the Gap Between the Knowledge of General Practitioners and Dermatologists in a Brazilian Population
verfasst von
Andrea Quadros Garrido
Alberto Julius Alves Wainstein
Marina Patrus Ananias Brandão
Fernando Augusto de Vasconcellos Santos
Flavia Vasques Bittencourt
Carolina Ledsham
Ana Paula Drummond-Lage
Publikationsdatum
19.03.2020
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 4/2020
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-020-01735-z

Weitere Artikel der Ausgabe 4/2020

Journal of Cancer Education 4/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.